Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HEICO Corp Class A
HEI.A
|
+$873M |
| 2 |
Ferguson
FERG
|
+$750M |
| 3 |
UnitedHealth
UNH
|
+$641M |
| 4 |
Apple
AAPL
|
+$619M |
| 5 |
Visa
V
|
+$612M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vale
VALE
|
+$814M |
| 2 |
Pinduoduo
PDD
|
+$699M |
| 3 |
Meta Platforms (Facebook)
META
|
+$470M |
| 4 |
Home Depot
HD
|
+$382M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Financials | 13.06% |
| 3 | Healthcare | 12.67% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Precision BioSciences
DTIL
$178M
| $71K | ﹤0.01% |
762
+4
| +0.5% | +$543 |
|
3777
Citizens
CIA
$248M
| $69K | ﹤0.01% |
16,163
+502
| +3% | +$2.27K |
|
3778
HF Foods Group
HFFG
$80.7M
| $69K | ﹤0.01% |
10,423
-40,721
| -80% | -$282K |
|
3779
Kopin
KOPN
$586M
| $69K | ﹤0.01% |
27,136
+346
| +1% | +$996 |
|
|
ZY
3780
DELISTED
Zymergen Inc. Common Stock
ZY
| $69K | ﹤0.01% |
23,953
+355
| +2% | +$1.51K |
|
|
GAN
3781
DELISTED
GAN Ltd
GAN
| $68K | ﹤0.01% |
14,093
-208
| -1% | -$1.34K |
|
|
ESPR
3782
DELISTED
Esperion Therapeutics
ESPR
| $65K | ﹤0.01% |
+14,105
| New | +$60.5K |
|
3783
Oric Pharmaceuticals
ORIC
$1.17B
| $65K | ﹤0.01% |
12,167
+157
| +1% | +$1.41K |
|
3784
Stereotaxis
STXS
$133M
| $64K | ﹤0.01% |
17,282
-3,148
| -15% | -$14.9K |
|
3785
CytomX Therapeutics
CTMX
$690M
| $63K | ﹤0.01% |
23,628
+729
| +3% | +$2.8K |
|
|
EPZM
3786
DELISTED
Epizyme, Inc
EPZM
| $63K | ﹤0.01% |
54,442
-12,494
| -19% | -$20.4K |
|
3787
Lexicon Pharmaceuticals
LXRX
$1.03B
| $62K | ﹤0.01% |
29,849
+1,071
| +4% | +$2.97K |
|
3788
CEL-SCI Corp
CVM
$19.9M
| $61K | ﹤0.01% |
517
-12
| -2% | -$1.95K |
|
|
NNDM
3789
Nano Dimension
NNDM
$314M
| $61K | ﹤0.01% |
17,049
-3,596
| -17% | -$13K |
|
3790
Rekor Systems
REKR
$82.6M
| $61K | ﹤0.01% |
13,422
+192
| +1% | +$904 |
|
3791
Cue Biopharma
CUE
$118M
| $60K | ﹤0.01% |
415
-4
| -1% | -$848 |
|
3792
Alaunos Therapeutics
TCRT
$4.64M
| $60K | ﹤0.01% |
614
-19
| -3% | -$2.44K |
|
3793
Citius Pharmaceuticals
CTXR
$15.6M
| $59K | ﹤0.01% |
1,308
+28
| +2% | +$1.11K |
|
3794
Denison Mines
DNN
$2.43B
| $59K | ﹤0.01% |
36,694
-26,249
| -42% | -$37K |
|
3795
CorMedix
CRMD
$564M
| $58K | ﹤0.01% |
10,675
-228
| -2% | -$1.04K |
|
|
EXK
3796
Endeavour Silver
EXK
$2.24B
| $57K | ﹤0.01% |
12,399
-5,628
| -31% | -$24.5K |
|
3797
Ultrapar
UGP
$6.66B
| $57K | ﹤0.01% |
+18,651
| New | +$50.6K |
|
|
GRTS
3798
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $57K | ﹤0.01% |
13,885
-730,715
| -98% | -$3.87M |
|
|
HGEN
3799
DELISTED
HUMANIGEN, INC.
HGEN
| $57K | ﹤0.01% |
19,032
-146
| -0.8% | -$391 |
|
|
EAR
3800
DELISTED
Eargo, Inc. Common Stock
EAR
| $55K | ﹤0.01% |
+519
| New | +$51.3K |
|
Similar funds
Invesco's Q1 2022 Portfolio in Review
As of Q1 2022, Invesco held 4,189 positions worth $392B, down 5.5% from $415B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Invesco's Q1 2022 filing shows 137 new, 2,071 increased, 1,612 reduced and 191 closed positions. Its largest new stake was Ferguson: 4,859,882 shares worth $652M. The largest sale was Vale, an estimated $814M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
- Invesco's largest Q1 2022 buy was Ferguson: 4,859,882 shares worth $652M.
- Invesco added most to HEICO Corp Class A in Q1 2022, an estimated $873M increase.
- Invesco's biggest Q1 2022 reduction was Vale, cutting an estimated $814M.
- Invesco fully exited Xilinx Inc in Q1 2022, selling an estimated $200M.
- Invesco's ten largest holdings make up 12% of its $392B portfolio in Q1 2022.
- Invesco opened 137 new positions and closed 191 in Q1 2022.
- Invesco's portfolio value fell 5.5% quarter-over-quarter to $392B.
Based on Invesco's 13F filing for Q1 2022, filed 16 May 2022.